- Home
- Standardized Extracts
- Caralluma Extract
Caralluma Extract (Caralluma fimbriata) – Pregnane Glycosides 10–25%
Caralluma fimbriata
- Marker compound
- Pregnane glycosides
- Standardisation
- 10–25% (HPLC)
- Assay method
- HPLC
- Plant part
- Aerial Parts
- Origin
- India
Caralluma Extract (Caralluma fimbriata) – Pregnane Glycosides 10–25%
Caralluma extract is produced from the aerial parts of Caralluma fimbriata (Apocynaceae family) and supplied as a standardized extract powder, standardized to Pregnane glycosides. Available grades: 10%, 15%, 25%. Typical sourcing: India. For B2B formulation in nutraceuticals & supplements.
10%15%25%
Specifications
| Botanical name | Caralluma fimbriata |
| Common names | Caralluma |
| Plant family / part | Apocynaceae / Aerial parts |
| Marker compound | Pregnane glycosides |
| Phytochemical class | Steroids & steroidal saponins › Steroidal saponins & sapogenins |
| Available grades | 10%, 15%, 25% |
| Made-to-order grades | 15% (produced on request; confirm lead time) |
| Assay method | HPLC |
| Pharmacopoeia & standards | US GRAS notice |
| Form | Standardized Extract |
| Origin | India |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Weight Management
Industries
Nutraceuticals & Supplements
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form